Evidence map›Paper›PMID 41892404›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Trends, Seasonality, and the Impact of COVID-19 on Clinical

Jaime Briseno-Ramírez, Pedro Martínez-Ayala, Adolfo Gómez-Quiroz, Brenda Berenice Avila-Cardenas, Brian Rafael Rubio-Mora, Roberto Miguel Damian-Negrete, Ana María López-Yáñez, Leonardo García-Miranda, Carlos Roberto Álvarez-Alba, Judith Carolina De Arcos-Jiménez

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Whole-genome sequencing ofMicrobiology spectrum · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jaime Briseno-RamírezHospital Civil de Oriente, Tónala 45425, Mexico.ORCID 0009-0006-1901-392X
Pedro Martínez-AyalaAntiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.ORCID 0000-0002-0505-6340
Adolfo Gómez-QuirozAntiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Brenda Berenice Avila-CardenasAntiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Brian Rafael Rubio-MoraAntiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.ORCID 0009-0009-2891-924X
Roberto Miguel Damian-NegreteDivisión Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Zuñiga 45641, Mexico.ORCID 0000-0003-3424-1382
Ana María López-YáñezHospital Civil de Oriente, Tónala 45425, Mexico.
Leonardo García-MirandaDivisión Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Zuñiga 45641, Mexico.ORCID 0009-0005-5669-7227
Carlos Roberto Álvarez-AlbaAntiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.ORCID 0009-0000-7428-899X
Judith Carolina De Arcos-JiménezHospital Civil de Oriente, Tónala 45425, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesMethicillin-resistant

methodsWe analyzed 6625 non-duplicate clinical

resultsMRSA prevalence declined from 28.1% pre-pandemic to 14.0% post-peak (Mann-Kendall

conclusionsMRSA declined markedly across the study period, with the steepest reduction following the Omicron peak. The decline persisted after adjustment for pandemic-related fluctuations in hospital volume, supporting periodic reassessment of empiric anti-MRSA prescribing policies in similar settings.

Indexed as

antimicrobial resistanceCOVID-19 pandemicinterrupted time seriesmethicillin-resistant Staphylococcus aureusStaphylococcus aureustime series analysis

Identifiers

PMID41892404
PMCPMC13024594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.